Brugada syndrome drugs to preferably avoid: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{WH}}" |
No edit summary |
||
| Line 1: | Line 1: | ||
{{ | |||
==Overview== | |||
The following drugs should be avoided in patients with Brugada syndrome. <ref>www.brugadadrugs.org</ref><ref name="pmid19716089">{{cite journal |author=Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA |title=Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) |journal=[[Heart Rhythm : the Official Journal of the Heart Rhythm Society]] |volume=6 |issue=9 |pages=1335–41 |year=2009 |month=September |pmid=19716089 |pmc=2779019 |doi=10.1016/j.hrthm.2009.07.002 |url=http://linkinghub.elsevier.com/retrieve/pii/S1547-5271(09)00739-5 |issn= |accessdate=2012-10-13}}</ref> | |||
Revision as of 22:42, 13 October 2012
Overview
The following drugs should be avoided in patients with Brugada syndrome. [1][2]
- ↑ www.brugadadrugs.org
- ↑ Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA (2009). "Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)". Heart Rhythm : the Official Journal of the Heart Rhythm Society. 6 (9): 1335–41. doi:10.1016/j.hrthm.2009.07.002. PMC 2779019. PMID 19716089. Retrieved 2012-10-13. Unknown parameter
|month=ignored (help)